| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $82.4M | -2.6% |
| SG&A Expense | $26.2M | -23.2% |
| Operating Income | -$88.9M | -11.0% |
| Pre-tax Income | -$92.7M | -11.6% |
| Income Tax | $53K | — |
| Net Income | -$92.7M | -11.7% |
| EPS (Basic) | -$1.65 | -10.0% |
| EPS (Diluted) | -$1.65 | -10.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.2M | +28.8% |
| Short-term Investments | $28.9M | -75.6% |
| Current Assets | $68.3M | -53.9% |
| Total Assets | $97.5M | -49.3% |
| Current Liabilities | $57.1M | +22.3% |
| Long-term Debt | $36.2M | +2.0% |
| Total Liabilities | $112.7M | -11.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.0M | -193.0% |
| Capital Expenditures | $3.2M | -20.0% |
| Investing Cash Flow | $95.3M | +252.7% |
| Financing Cash Flow | -$265K | -100.3% |
| Free Cash Flow | -$92.2M | -168.2% |
| Stockholders' Equity |
| -$15.1M |
| -123.0% |